Jump Financial, LLC Assertio Holdings, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.07 - $1.75 $18,895 - $30,903	-17,659 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.75 - $1.31 $13,244 - $23,133	17,659 New	17,659 $21,000
Q3 2023 Oct 21, 2024	BUY	$2.52 - $5.69 $166,027 - $374,879	65,884 Added 636.38%	76,237 $195,000
Q3 2023 Nov 07, 2023	BUY	$2.52 - $5.69 $166,027 - $374,879	65,884 Added 636.38%	76,237 $195,000
Q2 2023 Oct 21, 2024	SELL	$5.0 - $7.66 $36,530 - $55,963	-7,306 Reduced 41.37%	10,353 $56,000
Q2 2023 Aug 07, 2023	BUY	$5.0 - $7.66 $51,765 - $79,303	10,353 New	10,353 $56,000
Q4 2022 Feb 13, 2023	SELL	$2.11 - $4.3 $59,909 - $122,089	-28,393 Reduced 70.28%	12,007 $51,000
Q3 2022 Nov 07, 2022	BUY	$2.13 - $4.0 $86,052 - $161,600	40,400 New	40,400 $92,000

31.4M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $40.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.